SCHEMBL13613643

SCHEMBL13613643

COC(=O)c1ccc(CNC(=O)Nc2cccc3c2CC(O)CC3)cc1

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 11/20 0.48
OPRM1 P35372 1/20 0.46
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 3/20 0.46
GAA P10253 2/20 0.46
HDAC1 Q13547 2/20 0.44
HDAC6 Q9UBN7 2/20 0.44
HDAC11 Q96DB2 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
NAMPT P43490 1/20 0.41
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13613614 0.89 KDM4E (0.56) TRPV1OPRM1ALDH1A1KDM4EMEN1
SCHEMBL13613649 0.89 TRPV1 (0.53) TRPV1OPRM1KDM4E
SCHEMBL13613609 0.87 TRPV1 (0.51) TRPV1OPRM1ALDH1A1KDM4EGAA
SCHEMBL2734754 0.86 KDM4E (0.53) TRPV1OPRM1ALDH1A1KDM4EMEN1
SCHEMBL13613606 0.86 TRPV1 (0.59) TRPV1OPRM1KDM4E
SCHEMBL13613629 0.85 TRPV1 (0.53) TRPV1OPRM1ALDH1A1MEN1KMT2A
SCHEMBL13613650 0.85 TRPV1 (0.51) TRPV1OPRM1KDM4E
SCHEMBL13613612 0.85 TRPV1 (0.55) TRPV1OPRM1ALDH1A1KDM4EGAA
SCHEMBL13613627 0.85 TRPV1 (0.51) TRPV1OPRM1KDM4E
SCHEMBL13613637 0.84 TRPV1 (0.53) TRPV1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed
US-7612113-B2 Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD XENTION LIMITED (GB) 2009-11-03 US disclosed